Lapaquistat (TAK-475) is a cholesterol-lowering drug candidate that was abandoned before being marketed.
{{Infobox drug | Verifiedfields = changed | verifiedrevid = 462088993 | IUPAC_name = (1-{[(3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]acetyl}piperidin-4-yl)acetic acid | image = Lapaquistat.svg | image_class = skin-invert-image
| tradename =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).